Synopsys, Inc. SNPS

NASDAQ · Technology · Software - Infrastructure

$396.17

Close on Fri, 20 Nov 2026 · market value $75.9B

What the price is betting on

Below its record

At $396, the price assumes revenue grows about 13% a year for five years, from $9.4B to about $15.8B by FY2030. That is about the same as what analysts expect for the next two years and less than the company's own last three years.

The price assumes13%
Analysts, next two years14%
Last 3 years23%

Revenue growth a year. The price figure comes from a reverse DCF at a 9.6% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than SNPS? Check up to 5 of your stocks at once, free, no account.

0$5B$10B$15B$20B$9.4B'22'23'24'25Jul '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$318

Base

$428

Bull

$576

Today $396

  • Bear $318. Cash flow grows 9% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $428. Cash flow grows 14% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $576. Cash flow grows 20% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$9.7B$9.7B, on the path
  3. FY2027$11B$11.1B, on the path
  4. FY2028$12.4B$12.6B, on the path
  5. FY2029$14B$14.6B, on the path
  6. FY2030$15.8B$16.3B, on the path

Each year's revenue at 13% growth from $9.4B in the 12 months to July 2026.

At a glance

Technology · Software - Infrastructure · listed on NASDAQ

Revenue, FY2025
$7.1B
Growth, 3 years a year
23%
Cash margin
19%
Net debt
$11.3B
Shares, 3-year change
+5.9%
Dividend yield
0%

What other technology prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.